- Home
- FTDR vs TFX Comparison
FTDR vs TFX Comparison
Compare FTDR & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTDR
- TFX
- Stock Information
- Founded
- FTDR 1971
- TFX 1943
- Country
- FTDR United States
- TFX United States
- Employees
- FTDR N/A
- TFX N/A
- Industry
- FTDR Diversified Commercial Services
- TFX Medical/Dental Instruments
- Sector
- FTDR Finance
- TFX Health Care
- Exchange
- FTDR Nasdaq
- TFX Nasdaq
- Market Cap
- FTDR 4.4B
- TFX 5.1B
- IPO Year
- FTDR 2018
- TFX N/A
- Fundamental
- Price
- FTDR $66.66
- TFX $130.59
- Analyst Decision
- FTDR Hold
- TFX Hold
- Analyst Count
- FTDR 4
- TFX 9
- Target Price
- FTDR $59.75
- TFX $141.57
- AVG Volume (30 Days)
- FTDR 639.7K
- TFX 585.6K
- Earning Date
- FTDR 11-03-2025
- TFX 10-30-2025
- Dividend Yield
- FTDR N/A
- TFX 1.04%
- EPS Growth
- FTDR 29.61
- TFX N/A
- EPS
- FTDR 3.36
- TFX 4.18
- Revenue
- FTDR $1,966,000,000.00
- TFX $3,041,342,000.00
- Revenue This Year
- FTDR $14.54
- TFX $10.16
- Revenue Next Year
- FTDR $6.49
- TFX $10.10
- P/E Ratio
- FTDR $20.00
- TFX $31.20
- Revenue Growth
- FTDR 8.62
- TFX 1.11
- 52 Week Low
- FTDR $35.61
- TFX $108.90
- 52 Week High
- FTDR $67.23
- TFX $249.91
- Technical
- Relative Strength Index (RSI)
- FTDR 68.25
- TFX 60.79
- Support Level
- FTDR $63.31
- TFX $128.32
- Resistance Level
- FTDR $67.26
- TFX $133.18
- Average True Range (ATR)
- FTDR 2.00
- TFX 2.60
- MACD
- FTDR 0.51
- TFX 0.14
- Stochastic Oscillator
- FTDR 95.23
- TFX 72.55
About FTDR Frontdoor Inc.
Frontdoor Inc is a United States-based company that provides home service plans. It owns multiple home service brands including American Home Shield, HSA, OneGuard, and Landmark brands. Through its home service plans, the company helps its customers maintain their homes and protect against costly and unexpected breakdowns of essential home systems and appliances.
About TFX Teleflex Incorporated
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.